IRIS
TOMBOLINI, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 639
EU - Europa 365
AS - Asia 83
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 1.093
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 635
IE - Irlanda 169
CN - Cina 62
DE - Germania 52
SE - Svezia 49
IT - Italia 23
UA - Ucraina 22
GB - Regno Unito 17
TR - Turchia 13
BE - Belgio 12
FR - Francia 9
CZ - Repubblica Ceca 6
SG - Singapore 5
AU - Australia 3
CA - Canada 3
EU - Europa 3
RU - Federazione Russa 3
ES - Italia 1
FI - Finlandia 1
IL - Israele 1
IN - India 1
PA - Panama 1
PL - Polonia 1
VN - Vietnam 1
Totale 1.093
Salva come PNG Salva come JPEG
Città #
Chandler 192
Dublin 169
Jacksonville 95
Ann Arbor 45
Ashburn 35
New York 28
Wilmington 21
Lawrence 20
Princeton 20
Bremen 15
Boardman 12
Brussels 12
Nanjing 12
Beijing 11
Izmir 10
Woodbridge 8
Munich 7
Brno 6
L'aquila 6
San Mateo 6
Changsha 5
Des Moines 5
Falls Church 5
Grafing 5
Kunming 5
Shenyang 5
Berlin 4
Los Angeles 4
Milan 4
Mountain View 4
Nanchang 4
Washington 4
Norwalk 3
Seattle 3
Dearborn 2
Guangzhou 2
Hanover 2
Hebei 2
Lanzhou 2
Redwood City 2
Rome 2
Shanghai 2
Singapore 2
Tappahannock 2
Tianjin 2
Toronto 2
Beauharnois 1
Bellante 1
Canberra 1
Changchun 1
Chicago 1
Cormeilles-en-Parisis 1
Frankfurt am Main 1
Fremont 1
Hanoi 1
Irkutsk 1
Jiaxing 1
Krasnoyarsk 1
Logan 1
Madrid 1
Manchester 1
Marseille 1
Napoli 1
Ningbo 1
Panama City 1
Pune 1
Sydney 1
Taizhou 1
Tel Aviv 1
Teramo 1
Warsaw 1
Zhengzhou 1
Totale 840
Salva come PNG Salva come JPEG
Nome #
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma 93
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 88
Moderate hypofractionation in patients with low-risk prostate cancer: Long-term outcomes 85
HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells 85
New approaches in glioblastoma multiforme: The potential role of immune-check point inhibitors 81
Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results 65
Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization 64
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 56
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma 56
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program 55
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 53
Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines in Vitro and in Vivo 48
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines 46
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo 42
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis 42
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation 39
Phase 2 of coronavirus disease (COVID-19) and head and neck cancer: An action plan 36
Ms−275 (Entinostat) promotes radio-sensitivity in pax3-foxo1 rhabdomyosarcoma cells 32
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 32
Sinonasal Undifferentiated Carcinoma in a Patient Previously Treated for an Intestinal-Type Adenocarcinoma: Metachronous Neoplasms or Recurrence of a Different Tumor Type? 29
Totale 1.127
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 21 2 10 3 0 19 21 3 14 8 3 13
2020/2021129 3 12 1 16 14 4 21 1 19 8 25 5
2021/2022144 7 1 29 9 3 9 7 7 18 6 8 40
2022/2023491 30 42 6 80 33 52 0 24 200 6 12 6
2023/2024138 6 14 11 5 6 60 9 2 0 5 6 14
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.127